Standout Papers
Citation Impact
Citing Papers
Role of Genotype in the Cycle of Violence in Maltreated Children
2002 StandoutScience
Association between TCF7L2gene polymorphisms and susceptibility to Type 2 Diabetes Mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis
2009
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
2004 Standout
Prevention of Type 2 Diabetes Mellitus Through Inhibition of the Renin-Angiotensin System
2004
The Rising Prevalence of Diabetes and Impaired Glucose Tolerance
2002
Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin
2004
Relation of Serial Changes in Childhood Body-Mass Index to Impaired Glucose Tolerance in Young Adulthood
2004
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Early detection of undiagnosed diabetes mellitus: a US perspective
2000
mTOR Signaling in Growth Control and Disease
2012 Standout
The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)—methods and response rates
2002
The worldwide epidemic of diabetic retinopathy
2012
Genotype Score in Addition to Common Risk Factors for Prediction of Type 2 Diabetes
2008
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Global burden of hypertension: analysis of worldwide data
2005 Standout
The Quality of Health Care Delivered to Adults in the United States
2003 Standout
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants
2011 Standout
Candidate Gene Association Study in Type 2 Diabetes Indicates a Role for Genes Involved in β-Cell Function as Well as Insulin Action
2003
Diabetes in sub-Saharan Africa
2010
Atomic structures of amyloid cross-β spines reveal varied steric zippers
2007 StandoutNature
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
2015 Standout
Prevalence of diagnosed type 2 diabetes mellitus in the French general population: The INSTANT study
2008
Rehospitalizations among Patients in the Medicare Fee-for-Service Program
2009 Standout
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Preventing Type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view
2003
The prevalence of hypertension and diabetes defined by fasting and 2‐h plasma glucose criteria in urban Nepal
2006
Prevalence of Diabetic Retinopathy in Various Ethnic Groups: A Worldwide Perspective
2012
Preventing diabetes — applying pathophysiological and epidemiological evidence
2000
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
2007 StandoutNature
Diabetes in Ghana: a community based prevalence study in Greater Accra
2002
Role of Prasugrel, a Novel P2Y12 Receptor Antagonist, in the Management of Acute Coronary Syndromes
2009
Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus
2004
Study Rationale and Design of ADVANCE: Action in Diabetes and Vascular disease - preterax and diamicron MR controlled evaluation
2001
Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes Mellitus<SUBTITLE>Progressive Requirement for Multiple Therapies (UKPDS 49)</SUBTITLE>
1999 Standout
Type II Diabetes Mellitus and impaired glucose tolerance in Yemen: prevalence, associated metabolic changes and risk factors
2004
Interventions used in disease management programmes for patients with chronic illness---which ones work? Meta-analysis of published reports
2002
Wnt/β-Catenin Signaling and Disease
2012 Standout
The Effect of Mediterranean Diet on Metabolic Syndrome and its Components
2011
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
2017 Standout
The role of ethnicity in predicting diabetes risk at the population level
2012
Diabetes and associated disorders in Cambodia: two epidemiological surveys
2005
Reducing the Global Burden of Cardiovascular Disease: The Role of Risk Factors
2002
Animal evidence for the transgenerational development of diabetes mellitus
2005
Initial sequence of the chimpanzee genome and comparison with the human genome
2005 StandoutNature
Global and societal implications of the diabetes epidemic
2001 StandoutNature
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Diabetes: a 21st century challenge
2013
Gut metagenome in European women with normal, impaired and diabetic glucose control
2013 StandoutNature
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
Globalization, coca‐colonization and the chronic disease epidemic: can the Doomsday scenario be averted?
2000
Hypomagnesaemia and risk for metabolic glucose disorders: a 10‐year follow‐up study
2008
Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data
1998
IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030
2011 Standout
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
2017 Standout
Glucose intolerance and associated factors in Mongolia: results of a national survey
2002
Prevalence of diabetes in Pakistan
2006
The UKPDS and its global impact
2008
Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in a rural area of Japan
2000
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: A prospective population-based study in The Netherlands (ZODIAC-1)
2003
The global diabetes pandemic: the Tunisian experience
2006
The metabolic syndrome—a new worldwide definition
2005 Standout
The Parallel Superpleated Beta-structure as a Model for Amyloid Fibrils of Human Amylin
2005
Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995–2005: a population-based study
2007
Diabetes and impaired glucose tolerance in Jordan: prevalence and associated risk factors
1998
High prevalence of undiagnosed diabetes mellitus in Southern Germany: Target populations for efficient screening. The KORA survey 2000
2003
Does disease management improve clinical and economic outcomes in patients with chronic diseases? A systematic review
2004
Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α
2006 Standout
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
2002 Standout
Neonatal anthropometry: the thin–fat Indian baby. The Pune Maternal Nutrition Study
2003
Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999–2004: a national health insurance data set study
2010
Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA)
2003
Prevalence and treatment of diabetes in France: Trends between 2000 and 2005
2008
The Path to Personalized Medicine
2010 Standout
Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk)
2001
Global estimates of the prevalence of diabetes for 2010 and 2030
2009 Standout
Redefining Type 2 diabetes: ‘Diabesity’ or ‘Obesity Dependent Diabetes Mellitus’?
2000
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
Influence of anxiety on health outcomes in COPD
2010
Prevalence and correlates of diabetes mellitus and impaired glucose tolerance among adults in Luzon, Philippines
2003
Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment
2006
Effect of In Utero and Early-Life Conditions on Adult Health and Disease
2008 Standout
Evolution, consequences and future of plant and animal domestication
2002 StandoutNature
The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes
2003 Standout
Adherence to Medication
2005 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
First diabetes prevalence study in Portugal: PREVADIAB study
2010
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Dissecting racial bias in an algorithm used to manage the health of populations
2019 StandoutScience
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Prevalence and Management of Diabetes in Korean Adults
2009
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Prevalence of Diabetes and Impaired Fasting Glucose in Korea
2006
The Rate and Cost of Hospital Readmissions for Preventable Conditions
2004
Characteristics of Patients With Type 2 Diabetes in Mexico
2003
Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations
1999
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Population-Based Study of Diabetes and Risk Characteristics in Turkey
2002
Socio‐economic status, obesity and prevalence of Type 1 and Type 2 diabetes mellitus
2000
The importance of postprandial glucose concentration: lessons learned from diabetes and pregnancy
2006
Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study.
2001
Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease
2016
Pharmacologic Therapy for Type 2 Diabetes Mellitus
1999
Insulin Resistance Accelerates Muscle Protein Degradation: Activation of the Ubiquitin-Proteasome Pathway by Defects in Muscle Cell Signaling
2006
Global Prevalence of Diabetes
2004 Standout
Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations
1999
Prevalence of diabetes mellitus in Croatia
2008
Mitochondrial Dysfunction and Type 2 Diabetes
2005 StandoutScience
Nonfasting Lipids, Lipoproteins, and Apolipoproteins in Individuals with and without Diabetes: 58 434 Individuals from the Copenhagen General Population Study
2010
Cutoff Values for Normal Anthropometric Variables in Asian Indian Adults
2003
Adaptation and Maladaptation of the Heart in Diabetes: Part II
2002
Prevalence of Diabetes and Impaired Glucose Tolerance in 64-Year-Old Swedish Women
2006
A Diabetes Report Card for the United States: Quality of Care in the 1990s
2002
Prevalencia de diabetes mellitus en la provincia de Girona, España: el estudio REGICOR
2004
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
2011
Effects of Intensive Glucose Lowering in Type 2 Diabetes
2008 Standout
Magnesium Intake and Risk of Type 2 Diabetes in Men and Women
2004
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
2007 StandoutNobel
The Prevalence and Management of Diabetes in Thai Adults
2003
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial
2003 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Nonalcoholic Fatty Liver Disease
2015 Standout
Empagliflozin improves glycaemic and weight control as add‐on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: a 24‐week, randomized, placebo‐controlled trial
2013
Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance
2003 StandoutScience
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
2002
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
2002 Standout
Prevalence of Diabetes Mellitus in the Province of Girona, Spain: the REGICOR Study
2004
Works of Ronald E. Aubert being referenced
Is there a relationship between early statin compliance and a reduction in healthcare utilization?
2010
Diabetes Mellitus in Egypt: Risk Factors and Prevalence
1995
Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications
1998
Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes
2010
Comparative Analysis of Two Quality-of-Life Instruments for Patients with Chronic Obstructive Pulmonary Disease
2002
Pharmacogenomic Biomarker Information in Drug Labels Approved by the United States Food and Drug Administration: Prevalence of Related Drug Use
2008
Determinants of Adherence to Diabetes Medications: Findings From a Large Pharmacy Claims Database
2015
Comparison of Fasting and 2-Hour Glucose and HbA1c Levels for Diagnosing Diabetes: Diagnostic criteria and performance revisited
1997
Nurse Case Management To Improve Glycemic Control in Diabetic Patients in a Health Maintenance Organization
1998
A New and Simple Questionnaire to Identify People at Increased Risk for Undiagnosed Diabetes
1995
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
1998 Standout
Population-Based Assessment of the Level of Care Among Adults With Diabetes in the U.S
1998
Abstract 3998: Proton Pump Inhibitors Effect on Clopidogrel Effectiveness: The Clopidogrel Medco Outcomes Study
2008
Renal assessment practices and the effect of nurse case management of health maintenance organization patients with diabetes.
1999